Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21139245rdf:typepubmed:Citationlld:pubmed
pubmed-article:21139245lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:21139245lifeskim:mentionsumls-concept:C0242726lld:lifeskim
pubmed-article:21139245lifeskim:mentionsumls-concept:C1886714lld:lifeskim
pubmed-article:21139245lifeskim:mentionsumls-concept:C0038333lld:lifeskim
pubmed-article:21139245lifeskim:mentionsumls-concept:C0384853lld:lifeskim
pubmed-article:21139245lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:21139245lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:21139245pubmed:issue12lld:pubmed
pubmed-article:21139245pubmed:dateCreated2010-12-8lld:pubmed
pubmed-article:21139245pubmed:abstractTextThe 5-HT? receptor (5-HT?R) is a member of the class of recently discovered 5-hydroxytryptamine (5-HT) receptors. Due to the lack of selective 5-HT?R ligands, the cellular signaling mechanisms of the 5-HT?R are poorly understood. We previously developed a cell-based high-throughput screening (HTS) method for the 5-HT?R and screened synthetic chemical compounds. In the present study, we expanded our screening into natural products to find novel 5-HT?R ligands. We found that the ethyl acetate fraction from the root of Caragana sinica (537-18BE) produced the most potent antagonistic activity. After further isolation of 537-18BE, we found that three stilbene derivatives, (+)-?-viniferin, miyabenol C and pallidol, are active constituents of 537-18BE inhibiting the 5-HT?R. Among them, (+)-?-viniferin showed the most potent inhibition, and miyabenol C also produced a considerable inhibition. When examined effects on other neurotransmitters for selectivity, 537-18BE and three stilbene derivatives did not produce any notable effects on 5-HT?, 5-HT?, or muscarinic acetylcholine M1 (M(1)) receptors. Furthermore, 5-HT?R antagonistic effects of (+)-?-viniferin, miyabenol C and pallidol were confirmed on extracellular signal-regulated kinase 1 and 2 (ERK1/2) which exerts effects in downstream pathways of 5-HT?R activation.lld:pubmed
pubmed-article:21139245pubmed:languageenglld:pubmed
pubmed-article:21139245pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:citationSubsetIMlld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21139245pubmed:statusMEDLINElld:pubmed
pubmed-article:21139245pubmed:issn1347-5215lld:pubmed
pubmed-article:21139245pubmed:authorpubmed-author:JinChangbaeClld:pubmed
pubmed-article:21139245pubmed:authorpubmed-author:RhimHyewhonHlld:pubmed
pubmed-article:21139245pubmed:authorpubmed-author:ChungKwang...lld:pubmed
pubmed-article:21139245pubmed:authorpubmed-author:KimHyoung...lld:pubmed
pubmed-article:21139245pubmed:authorpubmed-author:KimSoon-HeeSHlld:pubmed
pubmed-article:21139245pubmed:authorpubmed-author:KimDong...lld:pubmed
pubmed-article:21139245pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21139245pubmed:volume33lld:pubmed
pubmed-article:21139245pubmed:ownerNLMlld:pubmed
pubmed-article:21139245pubmed:authorsCompleteYlld:pubmed
pubmed-article:21139245pubmed:pagination2024-8lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:meshHeadingpubmed-meshheading:21139245...lld:pubmed
pubmed-article:21139245pubmed:year2010lld:pubmed
pubmed-article:21139245pubmed:articleTitleStilbene derivatives as human 5-HT(6) receptor antagonists from the root of Caragana sinica.lld:pubmed
pubmed-article:21139245pubmed:affiliationKorea Institute of Science and Technology, Seoul, Korea.lld:pubmed
pubmed-article:21139245pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21139245pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed